Knowledge Center
Patent / Jan 11, 2024
Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation
Source:
WO 2024009079 A1
The present invention describes a dry powder inhaler pharmaceutical composition comprising one or more active pharmaceutical ingredients (API) coated with one or more force control agents (FCA) with optimized aerodynamic performance by micronizing crystalline API particles to the respirable range and coating the particles with a force control agent. The present invention also id pharmaceutical composition, and its use in medicine.
Ìý
Also in the Knowledge Center
/ Mar 02, 2021
Investigating crystallization tendency, miscibility, and molecular interactions of drug-polymer systems for the development of amorphous solid dispersions
Read more
Scientific Article
/ Jul 08, 2021
Augmenting Adaptive Machine Learning with Kinetic Modeling for Reaction Optimization
Read more
Scientific Article
Scientific Article